Eli Lilly’s crop of new products propelled ... s chief financial officer Josh Smiley on the company’s results call, adding that Trulicity “grew faster than the market, hosting an increase ...

The stock of Eli Lilly and Company LLY has declined 10.6% in a month ... which will make up for the decline in sales from ...

Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading pharmaceutical company that sells Trulicity, Verzenio, ...

"Eli Lilly and Company (NYSE:LLY) is a leading pharmaceutical company that develops diabetes, oncology, immunology and ...

Thanks for joining us for Eli Lilly and Company's Q3 2024 earnings call ... by Zepbound Mounjaro and partially offset by declines in Trulicity. Realized prices increased 11% in the U.S., primarily ...